Skip to Main Content

Paper Details

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal Cancer.
Cancer Discov
58
2018
BRAF, BRAFV600E, BRAFV600E Colorectal Cancer, EGFR, ERK, MAPK, MEK, cell, cell-free DNA, cfDNA, colorectal cancer, heterogeneous clones, multiple, patient, patients, pooled clone system, resistant clones, tumor
Author NameAffiliation
Dora Dias-SantagataMassachusetts General Hospital Cancer Center
Dora Dias-SantagataMassachusetts General Hospital
Anthony J IafrateMassachusetts General Hospital Cancer Center
Anthony J IafrateMassachusetts General Hospital
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Massachusetts Institute of Technology and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenBroad Institute of Massachusetts Institute of Technology and Harvard
  • 1 - 8

Datasets

Release 1.2